We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| EKF Diagnostics Holdings PLC | AQSE:EKF.GB | Aquis Stock Exchange | Ordinary Share | GB0031509804 | Ordinary Shares 1p |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.605 | 2.20% | 28.105 | 25.00 | 30.00 | 28.105 | 27.50 | 27.50 | 8,737 | 09:09:20 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMEKF
RNS Number : 4295O
EKF Diagnostics Holdings PLC
07 November 2016
EKF Diagnostics Holdings plc
("EKF", the "Company")
Trading update
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that early trading in Q4 of the current financial year has again been materially higher than budget and at a run-rate in excess of already revised market forecasts, upgraded following the trading update provided on 7 October 2016.
The Company now believes that it will achieve revenues of at least GBP36.5m and adjusted EBITDA for the year ending 31 December 2016 of at least GBP5.5m, therefore exceeding current market forecasts. The strong performance of the business is due to organic growth.
In addition, the Company announces that cash generation continues to be strong and now expects to be close to breakeven if not cash positive by the year end, and then cash positive in the first quarter, again ahead of the board's previous expectations.
The announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.
Hot Features
Premium
EKF Diagnostics Holdings plc www.ekfdiagnostics.com
Christopher Mills, Non-Executive Tel: 029 2071 0570
Chairman
Julian Baines, CEO
Richard Evans, FD & COO
Panmure Gordon (UK) Limited Tel: 020 7886 2500
(NOMAD & Joint Broker)
Freddy Crossley / Peter Steel
(Corporate Finance)
N+1 Singer (Joint Broker) Tel: 020 7496 3000
Alex Price / Alex Laughton-Scott
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584
391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTLLFIDLALSIIR
(END) Dow Jones Newswires
November 07, 2016 02:00 ET (07:00 GMT)
1 Year EKF Diagnostics Chart |
1 Month EKF Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
